Gilead Sciences Earnings
NASDAQ: GILDHealthcareDrug Manufacturers - GeneralUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 146.85 0.00%
Next earnings date
Thu, Oct 29, 2026
Fiscal period
Sep/2026
EPS estimate
$2.15
Gilead Sciences earnings summary
Gilead Sciences is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $2.15. In its most recent report on Aug 6, 2026 (Q2 2026), GILD posted EPS of $-8.45. Revenue for the quarter was $7.80 billion.
Quarterly EPS is down 641.7% from the same quarter a year earlier. Across the last 16 reports, GILD shares moved an average of 2.3% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
GILD earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-8.45 | — | +3.9% |
| May 7, 2026 | — | $1.61 | — | -1.3% |
| Feb 24, 2026 | — | $1.75 | — | -3.4% |
| Nov 7, 2025 | — | $2.43 | — | +5.2% |
| Aug 7, 2025 | — | $1.56 | — | -0.9% |
| May 7, 2025 | — | $1.04 | — | +5.8% |
| Feb 28, 2025 | — | $1.43 | — | +2.7% |
| Nov 12, 2024 | — | $1.00 | — | +2.0% |
| Aug 8, 2024 | — | $1.29 | — | +0.2% |
| May 8, 2024 | — | $-3.34 | — | +2.7% |
| Feb 23, 2024 | — | $1.14 | — | -1.7% |
| Nov 7, 2023 | — | $1.73 | — | -0.6% |
| Aug 4, 2023 | — | $0.83 | — | +1.7% |
| May 3, 2023 | — | $0.80 | — | -2.0% |
| Feb 22, 2023 | — | $1.29 | — | +0.5% |
| Nov 2, 2022 | — | $1.42 | — | +1.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.